Physician profile
James E Conti
NPI 1568614345
$504.50
in general payments reported to CMS, 2019-2025
10 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $73.10 · 2021: $28.14 · 2023: $12.83 · 2024: $30.06 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $144.64 | 2019-2025 | |
| Covidien Lp | $115.06 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $47.68 | 2019 | |
| Endogastric Solutions, INC | $40.97 | 2021-2023 | Esophyx |
| Novo Nordisk INC | $37.09 | 2025 | Wegovy |
| Pfizer INC. | $30.71 | 2019 | |
| Boston Scientific Corporation | $27.78 | 2020-2024 | Compliance Endokit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.00 | 2019 | |
| Ironwood Pharmaceuticals, INC | $21.60 | 2019 | |
| Exact Sciences Corporation | $15.97 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Conti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.